Vikram Purohit

Stock Analyst at Morgan Stanley

(1.00)
# 1,577
Out of 4,650 analysts
184
Total ratings
27.87%
Success rate
-14.92%
Average return

Stocks Rated by Vikram Purohit

Zenas BioPharma
Oct 8, 2024
Initiates: Overweight
Price Target: $40
Current: $20.59
Upside: +94.27%
Foghorn Therapeutics
Sep 24, 2024
Maintains: Equal-Weight
Price Target: $6$9
Current: $8.17
Upside: +10.16%
Genmab
Sep 11, 2024
Maintains: Equal-Weight
Price Target: $31
Current: $23.12
Upside: +34.08%
Acelyrin
Aug 19, 2024
Maintains: Equal-Weight
Price Target: $13$6
Current: $6.40
Upside: -6.25%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Overweight
Price Target: $59$64
Current: $50.64
Upside: +26.38%
Absci
Jul 3, 2024
Initiates: Overweight
Price Target: $7
Current: $4.17
Upside: +67.87%
Ascendis Pharma
May 16, 2024
Maintains: Equal-Weight
Price Target: $116$140
Current: $126.77
Upside: +10.44%
Axsome Therapeutics
Apr 29, 2024
Upgrades: Overweight
Price Target: $90$115
Current: $90.35
Upside: +27.28%
Exscientia
Apr 22, 2024
Maintains: Equal-Weight
Price Target: $7
Current: $5.11
Upside: +36.99%
ABIVAX Société Anonyme
Apr 11, 2024
Maintains: Equal-Weight
Price Target: $15$16
Current: $10.60
Upside: +50.94%
Initiates: Overweight
Price Target: $30
Current: $6.22
Upside: +382.32%
Maintains: Equal-Weight
Price Target: $20$22
Current: $8.48
Upside: +159.43%
Maintains: Overweight
Price Target: $45$10
Current: $8.56
Upside: +16.82%
Downgrades: Equal-Weight
Price Target: $46$6
Current: $2.39
Upside: +151.05%
Maintains: Equal-Weight
Price Target: $74$64
Current: $73.60
Upside: -13.04%
Maintains: Overweight
Price Target: $43$42
Current: $9.06
Upside: +363.58%
Maintains: Equal-Weight
Price Target: $8$11
Current: $6.74
Upside: +63.20%
Maintains: Equal-Weight
Price Target: $20$23
Current: $3.73
Upside: +503.22%
Maintains: Equal-Weight
Price Target: $38$41
Current: $48.49
Upside: -15.45%
Maintains: Equal-Weight
Price Target: $120$40
Current: $34.41
Upside: +16.25%
Initiates: Equal-Weight
Price Target: $13
Current: $1.72
Upside: +655.81%
Maintains: Equal-Weight
Price Target: $39$38
Current: $18.74
Upside: +102.77%
Maintains: Equal-Weight
Price Target: $24$20
Current: $10.35
Upside: +93.24%
Maintains: Underweight
Price Target: $11$10
Current: $8.65
Upside: +15.61%
Downgrades: Underweight
Price Target: $18$7
Current: $17.14
Upside: -59.16%
Initiates: Overweight
Price Target: $22
Current: $4.75
Upside: +363.16%
Maintains: Equal-Weight
Price Target: $8$4
Current: $0.82
Upside: +387.80%